Transition state for Lacy, Chazin at Vanderbilt
, a structural biologist at Vanderbilt University Medical Center, has been promoted from associate director to director of the Vanderbilt . She took over at the start of January.


The center for structural biology that Lacy now leads was founded in 1999. , the founding director who led the center for 21 years, said, “The center was designed and built around what was then an avant-garde concept of integrating all structural biology techniques together.”
Lacy has been a professor in Vanderbilt’s departments of pathology, microbiology, immunology and biochemistry since 2006. Her laboratory studies toxins from pathogenic bacteria, focusing on transmembrane secretion systems and pore-forming multimeric toxins from gastrointestinal pathogens such as Clostridium difficile and Helicobacter pylori. They also investigate how interactions between these proteins and the host can contribute to virulence.
Lacy earned her Ph.D. at the University of California, Berkeley and did postdoctoral research at Harvard Medical School. She is a fellow of the American Association for the Advancement of Science and of the American Academy of Microbiology
Chazin, the chancellor’s chair in medicine and a professor of biochemistry and chemistry, now will direct Vanderbilt's chemical and physical biology graduate program. His lab studies the structure of the priming engine, which synthesizes the RNA-DNA primers that DNA polymerases require for replication. The lab also works on protein complexes involved in responding to encounters with, and reversing, DNA damage, as well as innate immune responses to pathogenic organisms.
Chazin earned his Ph.D. at Concordia University in Montreal and did postdoctoral research at the Swiss Federal Institute of Technology in Zurich. He spent 13 years in the molecular biology department at Scripps Research before moving to Vanderbilt in 1999. He is a fellow of the American Association for the Advancement of Science and of the Biophysical Society.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles

In memoriam: Ralph G. Yount
He was a professor emeritus of chemistry and biochemistry at Washington State University and an ASBMB member for 58 years.

From dust to discovery
From makeshift classrooms in Uganda to postdoctoral research in Chicago, MOSAIC scholar Elizabeth Kaweesa builds a legacy in women鈥檚 health.

Fliesler wins scientific and ethical awards
He is being honored by the University at Buffalo and the American Oil Chemists' Society for his scientific achievements and ethical integrity.

Hope for a cure hangs on research
Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson鈥檚 fight for survival and hope. Without funding, science can鈥檛 鈥渃atch up鈥 to help the patients who need it most.

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease
Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal 鈥 and just getting started.

ASBMB members recognized as Allen investigators
Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.